"It was through the help of Canadian dermatologists that we have been able to grow the business."
In Conversation
"Life sciences have long been a focus for Ontario’s innovation economy and an important investment area for our government."
"Our vision is to become the leading travel vaccine company in Canada by being the preferred partner supporting health care providers in offering convenient and consistent…
"Unlike some of our competitors, we operate on a global formulations strategy, meaning that we can leverage our global manufacturing capacity to meet the needs of…
"A company like ours that is driven by innovation understands that there needs to be space for innovation."
"Canada is the only Western country without a rare disease framework. There is no official designation or recognition of rare diseases in Canada, which is a…
"Our weakest link is the industry-experienced drug developers and management teams. We need many more of the serial entrepreneur-type that loves to build and sell companies…
"Canada has traditionally been a very important market for Lundbeck but recent changes to the market access system in terms of both Health Technology Assessment (HTA)…
The senior management strongly believes that Canada is an important country for Dr. Reddy’s and certainly has the potential to become one-tenth of the US business…
"Novartis’ mantra is to either be first- or best-in-class. We are not going to introduce a ‘me, too’ drug."
"Health Canada is the market approval body but at the end of the day, it is the people within their walls that approve the drugs."
"Teva has had some really successful challenges to brand companies’ patented medicines where we were able to bring products to market early, thus saving millions of…
